Keenova Therapeutics plc announced positive results from its Phase 3 clinical trial of XIAFLEX (collagenase clostridium histolyticum) for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE